Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H K Nieuwenhuis

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Cancer|August 1, 1986
Treatment of disseminated intravascular coagulation in acute promyelocytic leukemia with low molecular weight heparinoid Org 10172H K Nieuwenhuis, J J Sixma
The Netherlands Journal of Medicine|February 1, 1997
Life-threatening anaemia caused by B19 parvovirus infection in a non-immunocompromised patientD H Biesma, H K Nieuwenhuis
Pharmaceutisch Weekblad. Scientific Edition|February 24, 1984
Agents interfering with the platelet-vessel wall interactionH K Nieuwenhuis, J J Sixma
Nederlands Tijdschrift Voor Geneeskunde|February 5, 2003
[Withdrawing the use of acetylsalicyclic acid prior to an operation usually not necessary]R Fijnheer, R T Urbanus, H K Nieuwenhuis
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[The Sebastian platelet syndrome. A new form of hereditary thrombocytopenia with giant thrombocytes and inclusion bodies in granulocytes]A Greinacher, H K Nieuwenhuis, J G White
Blut|November 1, 1990
Sebastian platelet syndrome: a new variant of hereditary macrothrombocytopenia with leukocyte inclusionsA Greinacher, H K Nieuwenhuis, J G White
Circulation|October 1, 1989
Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized studyJ Albada, H K Nieuwenhuis, J J Sixma
British Journal of Haematology|March 1, 1985
Differentiation of patients with subtype IIb-like von Willebrand's disease by means of perfusion experiments with reconstituted bloodK S Sakariassen, H K Nieuwenhuis, J J Sixma
Obstetrics and Gynecology|November 5, 1997
Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpuraG C Christiaens, H K Nieuwenhuis, J B Bussel
Cancer|May 1, 1990
Intermediate-dose cytosine arabinoside and amsacrine. An effective regimen with low toxicity in refractory acute nonlymphocytic leukemiaA W Dekker, H K Nieuwenhuis, L F Verdonck
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Cancer|August 1, 1986
Treatment of disseminated intravascular coagulation in acute promyelocytic leukemia with low molecular weight heparinoid Org 10172H K Nieuwenhuis, J J Sixma
The Netherlands Journal of Medicine|February 1, 1997
Life-threatening anaemia caused by B19 parvovirus infection in a non-immunocompromised patientD H Biesma, H K Nieuwenhuis
Pharmaceutisch Weekblad. Scientific Edition|February 24, 1984
Agents interfering with the platelet-vessel wall interactionH K Nieuwenhuis, J J Sixma
Nederlands Tijdschrift Voor Geneeskunde|February 5, 2003
[Withdrawing the use of acetylsalicyclic acid prior to an operation usually not necessary]R Fijnheer, R T Urbanus, H K Nieuwenhuis
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[The Sebastian platelet syndrome. A new form of hereditary thrombocytopenia with giant thrombocytes and inclusion bodies in granulocytes]A Greinacher, H K Nieuwenhuis, J G White
Blut|November 1, 1990
Sebastian platelet syndrome: a new variant of hereditary macrothrombocytopenia with leukocyte inclusionsA Greinacher, H K Nieuwenhuis, J G White
Circulation|October 1, 1989
Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized studyJ Albada, H K Nieuwenhuis, J J Sixma
British Journal of Haematology|March 1, 1985
Differentiation of patients with subtype IIb-like von Willebrand's disease by means of perfusion experiments with reconstituted bloodK S Sakariassen, H K Nieuwenhuis, J J Sixma
Obstetrics and Gynecology|November 5, 1997
Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpuraG C Christiaens, H K Nieuwenhuis, J B Bussel
Cancer|May 1, 1990
Intermediate-dose cytosine arabinoside and amsacrine. An effective regimen with low toxicity in refractory acute nonlymphocytic leukemiaA W Dekker, H K Nieuwenhuis, L F Verdonck
Pageof 9